Stigma, Insurance and
Access to Treatment and Services Emerge as Top Barriers to
Schizophrenics
(May 20, 2003) - A new national survey indicates that there are three major
barriers to improved quality of life for
people with schizophrenia and for
their caregivers -- stigma of mental
illness, inadequate insurance and access to treatment and
services.
The results of this National Mental Health Association survey were presented
in a press conference on May 20th at the Annual Meeting of the American
Psychiatric Association. In the U.S., about 2.2 million people have
schizophrenia.
"While it is the case that treatment and services are widespread in our
country, persons with this illness often have trouble navigating the system,
dealing with access and stigma issues and getting on the right drug
therapy," said presenter and investigator Peter Weiden, MD, Director of
Schizophrenia Research Service, professor of psychiatry, SUNY Downstate Medical
Center, in New York. "Good drugs exist but only if a patient can get to
them or get help developing a plan of treatment that will work for that
individual."
Harris Interactive Inc. conducted the "Barriers to Recovery"
survey from October 29 through December 19, 2002. They interviewed 1,087 adults
ages 18 and older, including 403 persons categorised as "aware of mental
illness in general," representing 90% of the total adult U.S. population.
The survey results identified 202 participants as knowing "someone with
a mental illness other than schizophrenia"; 201 knew "someone with
schizophrenia"; and 200 were identified as being unpaid caregivers for
people with schizophrenia.
Eighty-one participants recruited through the National Mental Health
Association had been diagnosed
with schizophrenia.
Regarding stigma, 58% of people with schizophrenia and 47% of caregivers say
that they believe schizophrenia can be treated successfully, while among other
respondents, 27% hold this view.
Among respondents who did not have schizophrenia and did not know anyone
with the condition, 50% said they believe people with depression can hold jobs
and 49% believe people with depression can raise families, but only 14% of
these same respondents believe that people with schizophrenia can do either
successfully.
Seventy percent of respondents with schizophrenia said it is difficult to
keep a positive attitude while dealing with illness-related stigma.
The survey results also shows that 48% of people with schizophrenia think
adequate services exist for people with mental illness, and 35% of caregivers
feel adequate services exist for families and friends dealing with mental
illness. Likewise, 52% of people with schizophrenia and 21% of caregivers
believe that insurance coverage for mental illness is on a par with coverage
for physical illness.
Lack of access means people with schizophrenia do not always receive the
latest standard of care medications for their specific illness, said Dr.
Weiden. The researcher reported that 70% of both caregivers and people with
schizophrenia express satisfaction with the results of their current
pharmacotherapy. But only 50% of caregivers and 62% of people with
schizophrenia are satisfied with their access to effective medications that do
not have significant side effects.
As for the economic effects of schizophrenia, 63% of caregivers indicated
difficulty in working full-time due to their role as a caregiver. The survey
results also showed that the average caregivers' household income is 13% lower
than that of the general public, despite parity in age and education.
In a press release distributed at the briefing, Chuck Ingoglia,
vice-president of research and services at the National Mental Health
Association, in Washington, D.C., said, "This survey proves what people
with schizophrenia and caregivers already knew regarding the barriers to an
improved quality of life. Now we need to reduce the barriers that people with
schizophrenia and caregivers face every day. A good start includes public
education, improved insurance legislation, and better access to appropriate
services and treatments."
The survey was supported by an unrestricted grant from Bristol-Myers Squibb
Co. and Otsuka America Pharmaceutical, Inc.
Read: How Others Can Help the Schizophrenic
and How Family Members Can Maintain Their Own
Health and Emotional Well-being
top ~
next ~
articles table of contents ~
send page to a
friend
|